This Article Full Text Full Text (PDF) All Versions of this Article: 27/2/189    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bieber, A. M. Articles by Robaire, B. Search for Related Content PubMed PubMed Citation Articles by Bieber, A. M. Articles by Robaire, B.

Effects of Chemotherapeutic Agents for Testicular Cancer on the Male Rat Reproductive System, Spermatozoa, and Fertility

ADRIENNE M. BIEBER^*,

LUDOVIC MARCON^*,

BERNARD ROBAIRE^*,

From the Departments of ^* Pharmacology & Therapeutics and Obstetrics & Gynecology, McGill University, Montréal, Québec, Canada.

Correspondence to: Bernard Robaire, Department of Pharmacology and Therapeutics, 3655 Promenade Sir-William-Osler, Montréal, Québec, Canada H3G 1Y6 (e-mail: Bernard.robaire{at}mcgill.ca).

Testicular cancer is the most common cancer affecting men of reproductive age. Advances in treatment of the disease, which include the coadministration of bleomycin, etoposide, and cis-platinum (BEP), have brought the cure rate to over 90%. This high cure rate, coupled with the young age of patients, makes elucidation of the impact of the treatment on reproductive function, fertility, and progeny outcome increasingly important. The goal of this study was to determine the effects of BEP, in doses analogous to those given to humans, on the male reproductive system, spermatozoa, fertility, and progeny outcome in an animal model. Male Sprague-Dawley rats were treated daily with BEP for 3 cycles of 3 weeks each, for a total of 9 weeks. After 6 and 9 weeks, males were mated to 2 groups of untreated females. BEP treatment resulted in decreases in testicular and epididymal weights of 52% and 28%, respectively, when compared to control. Decreased testis and epididymis weights were accompanied by impairment of spermatogenesis and by a decrease in spermatozoal count of nearly 90% (11.9 x 10⁷ spermatozoa per caput epididymidis in control vs 1.65 x 10⁷ in BEP-treated rats). The percent of motile spermatozoa in the treated rats was more than 30% lower than in controls. Defects in the flagella of spermatozoa increased by more than twofold in the midpiece, and by more than sixfold in the principal piece. Paternal BEP treatment, for either 6 or 9 weeks, did not affect fertility, pre- or postimplantation loss, litter size, or sex ratio among progeny on gestation day 21. In contrast, among the pregnancies allowed to proceed to delivery, a significant number of pups sired by males treated with BEP for 9 weeks died between birth and postnatal day 2; this was not observed in pups sired by males treated for 6 weeks. Markers of postnatal development were not affected in the surviving offspring from either group. Thus, despite the dramatic effects of the testicular cancer drug regimen on spermatogenesis, the numbers of spermatozoa, and their motility and morphology, male rats were fertile. While fetal development was apparently normal, early postnatal mortality, which may be associated with a delay in parturition, was elevated among the progeny sired by males exposed to BEP for 9 weeks.

     Key words: cis-Platinum, etoposide, bleomycin, testis, epididymis, progeny outcome, flagellar defect

This article has been cited by other articles:

				D. Chan, G. Delbes, M. Landry, B. Robaire, and J. M. Trasler Epigenetic Alterations in Sperm DNA Associated with Testicular Cancer Treatment Toxicol. Sci., February 1, 2012; 125(2): 532 - 543. [Abstract] [Full Text] [PDF]

				C. Paul, M. Nagano, and B. Robaire Aging Results in Differential Regulation of DNA Repair Pathways in Pachytene Spermatocytes in the Brown Norway Rat Biol Reprod, December 1, 2011; 85(6): 1269 - 1278. [Abstract] [Full Text] [PDF]

				L. Marcon, X. Zhang, B. F. Hales, B. Robaire, and M. C. Nagano Effects of Chemotherapeutic Agents for Testicular Cancer on Rat Spermatogonial Stem/Progenitor Cells J Androl, July 1, 2011; 32(4): 432 - 443. [Abstract] [Full Text] [PDF]

				L. Marcon, X. Zhang, B. F. Hales, M. C. Nagano, and B. Robaire Development of a Short-Term Fluorescence-Based Assay to Assess the Toxicity of Anticancer Drugs on Rat Stem/Progenitor Spermatogonia In Vitro Biol Reprod, August 1, 2010; 83(2): 228 - 237. [Abstract] [Full Text] [PDF]

				R. J. Ortiz, C. Lizama, V. A. Codelia, and R. D. Moreno A molecular evaluation of germ cell death induced by etoposide in pubertal rat testes Mol. Hum. Reprod., June 1, 2009; 15(6): 363 - 371. [Abstract] [Full Text] [PDF]

				G. Delbes, D. Chan, P. Pakarinen, J. M. Trasler, B. F. Hales, and B. Robaire Impact of the Chemotherapy Cocktail Used to Treat Testicular Cancer on the Gene Expression Profile of Germ Cells from Male Brown-Norway Rats Biol Reprod, February 1, 2009; 80(2): 320 - 327. [Abstract] [Full Text] [PDF]

				L. Marcon, B. F. Hales, and B. Robaire Reversibility of the Effects of Subchronic Exposure to the Cancer Chemotherapeutics Bleomycin, Etoposide, and Cisplatin on Spermatogenesis, Fertility, and Progeny Outcome in the Male Rat J Androl, July 1, 2008; 29(4): 408 - 417. [Abstract] [Full Text] [PDF]

				C. L Pin, C. L Johnson, B. Rade, A. S Kowalik, V. C Garside, and M. E Everest Identification of a Transcription Factor, BHLHB8, Involved in Mouse Seminal Vesicle Epithelium Differentiation and Function Biol Reprod, January 1, 2008; 78(1): 91 - 100. [Abstract] [Full Text] [PDF]

				G. Delbes, B. F. Hales, and B. Robaire Effects of the Chemotherapy Cocktail Used to Treat Testicular Cancer on Sperm Chromatin Integrity J Androl, March 1, 2007; 28(2): 241 - 249. [Abstract] [Full Text] [PDF]

				H. Chemes Editorial Commentary J Androl, March 1, 2007; 28(2): 250 - 251. [Full Text] [PDF]